Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy [Phase 2]
A Phase 2 trial evaluated the combination of docetaxel, estramustine, and thalidomide in men with prostate cancer previously treated with ho…
-
CLINICAL_TRIALS research · 2013-03-28Clinical Trial Update: Analysis of a New Biomarker for Prostate Cancer Diagnosis
This clinical trial update describes analysis of a new biomarker intended to aid the diagnosis of prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer [Phase 3]
This document reports on a Phase 3 trial comparing early versus delayed hormone therapy in nonmetastatic prostate cancer. The trial status i…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer [Phase 3]
Phase 3 study evaluating cyproterone acetate for hot flashes after surgical or chemical castration in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer [Phase 1]
Phase 1 trial evaluating a vaccine therapy plus QS21 in prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-03-25Clinical Trial Update: The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel
This clinical trial update investigates whether alpha-1 acid glycoprotein levels are associated with outcomes in metastatic cancer patients …
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]
Completed phase 1 and phase 2 clinical trials of a vaccine therapy in metastatic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy [Phase 3]
A long-term extension study evaluating a one-month degarelix dosing regimen for prostate cancer requiring androgen ablation therapy (Phase 3…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 1]
Phase 1 clinical trial of a vaccine therapy for metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating AMT2003 versus placebo in advanced cancer patients conducted by Auron Healthcare GmbH has been termina…
-
FDA approval · 2013-03-19FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, expanding the labeling to include an …
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer [Phase 1]
Phase 1 trial evaluating a combination of vaccine therapy and a biological therapy in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy with QS-21 adjuvant in patients with progressive prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer
Completed clinical trial evaluating the combination of Iodine-125 seed implants with LHRH agonists for locally advanced prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide [NA]
This clinical trial update reports the completion of a study evaluating initiation of androgen deprivation therapy for prostate cancer using…
-
FDA approval · 2013-03-13FDA Approved: JEVTANA — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for JEVTANA (cabazitaxel) submitted by Sanofi-Aventis U.S. LLC, representing a regulatory action…
-
FDA approval · 2013-03-12FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc.
-
FDA approval · 2013-03-12FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., indicating an updated labeling …
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC [Phase 1]
Phase I trial assessing ZD4054 (Zibotentan) in combination with docetaxel for metastatic castration-resistant prostate cancer; the study has…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Fulvestrant in Treating Patients With Advanced Prostate Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating fulvestrant for advanced prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer [Phase 3]
Phase 3 clinical trial of zoledronic acid for hormone-sensitive bone metastases from prostate cancer has completed with results posted in 20…
-
CLINICAL_TRIALS withdrawal · 2013-03-06Clinical Trial Update: Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating metformin with standard Taxotere (docetaxel) and prednisone in castration-resistant prostate cancer has …
-
FDA approval · 2013-03-05FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for FIRMAGON (degarelix) submitted by Ferring Pharmaceuticals Inc., confirming an approved modif…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: PROSTACOX : Metastatic Prostate Chemotherapy
This clinical trial update notes that the PROSTACOX study for metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Group Therapy Compared With Educational Materials in Patients With Prostate Cancer [NA]
A clinical trial comparing group therapy to educational materials for patients with prostate cancer has completed.